Autoimmune disease is complicated because the goal isn’t simply to “boost” the immune system — it’s an immune system that is misdirected or dysregulated.
Researchers are studying several peptides for their potential effects on inflammation, immune signaling, tissue repair, gut health, nerve symptoms, and immune balance. Here are some of the ones worth knowing about: 👇
🌿 KPV
One of my favorites to research when inflammation and gut issues are involved.
Potential areas being studied:
✨ Inflammatory signaling
✨ Gut/intestinal inflammation
✨ IBD-type inflammation
✨ Skin inflammation
✨ Cytokine regulation
Animal studies of KPV have shown anti-inflammatory activity in models of inflammatory bowel disease. (PubMed) 🧠 ARA-290 / Cibinetide
Especially interesting when an inflammatory or autoimmune condition includes:
✨ Burning or nerve pain
✨ Small-fiber neuropathy
✨ Autonomic symptoms
✨ Nerve damage
✨ Chronic inflammatory pain
ARA-290 has actually reached human trials in people with sarcoidosis-associated small-fiber neuropathy, where improvements in neuropathic symptoms and measures of nerve-fiber regeneration were reported. (PubMed) 💜 VIP – Vasoactive Intestinal Peptide
This is a fascinating immune-regulating neuropeptide.
Research has looked at VIP in connection with:
✨ Rheumatoid arthritis
✨ Crohn’s/IBD
✨ Multiple sclerosis
✨ Type 1 diabetes
✨ Sjögren’s
✨ Neuroinflammation
VIP appears capable of influencing both innate and adaptive immune responses and is being investigated more as an immune modulator than simply an immune suppressant or stimulant. Most autoimmune evidence is still experimental rather than established treatment. (PubMed Central (PMC)) 🩹 BPC-157
Potentially interesting when autoimmune illness comes with:
✨ GI irritation
✨ Gut-barrier problems
✨ Joint/tendon discomfort
✨ Tissue injury
✨ Chronic inflammation
BPC-157 has shown anti-inflammatory and tissue-healing effects in preclinical research, including models related to inflammatory bowel disease. Human evidence is still extremely limited, and it is not FDA-approved for treating autoimmune disease. (PubMed) 💙 GHK-Cu
Often discussed for much more than skin!
Research interest includes:
✨ Inflammatory regulation
✨ Wound and tissue repair
✨ Collagen/remodeling
✨ Oxidative stress
✨ Recovery of damaged tissue
Most of the systemic autoimmune interest here is still preclinical, so I think of GHK-Cu more as a tissue-repair/inflammation-support research peptide than an autoimmune treatment.
⚡ MOTS-C
A mitochondrial peptide being researched for:
✨ Mitochondrial function
✨ Metabolic inflammation
✨ Cellular stress
✨ Energy regulation
✨ Insulin sensitivity
This may be especially interesting because mitochondrial dysfunction and chronic inflammation can accompany several autoimmune illnesses, but direct autoimmune-treatment evidence is still early.
🧬 TB-500 / Thymosin Beta-4
Primarily researched for:
✨ Tissue repair
✨ Wound healing
✨ Angiogenesis
✨ Inflammatory regulation
✨ Muscle/tendon recovery
It could potentially support damage caused by chronic inflammation, but it does NOT currently have strong evidence as a direct autoimmune therapy.
🛡️ Thymosin Alpha-1 (TA-1)
This one needs a little more caution with autoimmune conditions.
TA-1 is a powerful immune-modulating peptide that can influence T cells, dendritic cells and innate immunity. That makes it extremely interesting — but an autoimmune patient does NOT necessarily want something simply because it “supports immunity.”
Autoimmune disease varies tremendously, and immune-stimulating effects could be inappropriate depending on the condition, medications and individual immune profile. TA-1 should therefore be considered much more condition-specific than something like KPV. (PubMed) ⚠️ AND ONE IMPORTANT ONE: LL-37
You may see LL-37 recommended online for inflammation or immune problems because it has strong antimicrobial and immunomodulatory activity.
But I would NOT put LL-37 on a general autoimmune-support list.
Research has actually implicated LL-37 in inflammatory pathways involved in conditions including:
❌ Psoriasis
❌ Lupus
❌ Rheumatoid arthritis
In psoriasis and lupus, LL-37 can interact with self-DNA and help drive inflammatory immune signaling. Autoimmune research with LL-37 is therefore complicated and can point in the OPPOSITE direction. (PubMed) 🌹 Some of the autoimmune conditions researchers are looking at in relation to peptide signaling include:
Lupus • Rheumatoid Arthritis • Hashimoto’s • Graves’ • Sjögren’s • Multiple Sclerosis • Psoriasis • Crohn’s • Ulcerative Colitis • Type 1 Diabetes • Sarcoidosis • Autoimmune neuropathies and more.
The exciting part of peptide research is that scientists aren’t only looking at suppressing the entire immune system — they’re studying ways of influencing inflammation, immune balance, tissue repair, the gut, mitochondria and nerve regeneration.
🌹 Bloom Theory Wellness
Education • Research • Women Helping Women 🧬✨